Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review
International Journal of Dermatology · 2026
DOI: 10.1111/ijd.70259 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Dermatology, 2026. Verfasst von Yagiz Matthew Akiska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Pruritus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Chronic pruritus of unknown origin (CPUO) is a distressing condition characterized by persistent itch lasting over 6 weeks without an identifiable cause. The underlying mechanisms remain poorly understood, complicating diagnosis and treatment. This systematic review examines the diagnostic work‐up and therapeutic approaches for CPUO, evaluating the quality of treatment studies using the Strength of Recommendation Taxonomy (SORT) algorithm. Our paper also uniquely integrates a review of potential pathogenic mechanisms. A comprehensive literature search was conducted in PubMed, EMBASE, Ovid MEDLINE, and Cochrane databases through September 2025 using terms including “CPUO,” “chronic idiopathic pruritus,” and “pruritus of unknown origin.” Studies discussing pathogenesis, diagnostic strategies, or treatment were included. Treatment interventions were assessed based on the SORT algorithm. Of 228 identified records, 52 met inclusion criteria: 18 addressing pathogenesis, 5 discussing competing etiological hypotheses, 3 focusing on diagnostic work‐up, 23 on treatment, and 3 on non‐pharmacological therapies. CPUO pathogenesis appears multifactorial, involving Th2 dysregulation, neurogenic factors (JAK1, GRPR, TRPV4), metabolic alterations, and aging‐related immune changes. Current diagnostic approaches emphasize exclusion of systemic, dermatologic, and neurologic causes. Treatment options include topical agents (calcineurin inhibitors, capsaicin), systemic immunomodulators (JAK inhibitors, dupilumab, nemolizumab), neuromodulators (gabapentin, pregabalin), and phototherapy. However, available treatment studies are of low quality, with few randomized controlled trials (RCTs). CPUO remains a challenging condition with unclear pathophysiology and limited high‐quality therapeutic evidence. Further research, particularly RCTs, is needed to establish evidence‐based management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Maryland Itch Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Yagiz Matthew Akiska, Isha Gandhi, Robert Adler, Deena Fayyad, Perya Bhagchandani, Shabnam Afzal, Waleed Adawi, Shawn G Kwatra
Zitieren
APA
Akiska, Y. M., Gandhi, I., Adler, R., Fayyad, D., Bhagchandani, P., Afzal, S., Adawi, W., Patel, S., & Kwatra, S. G. (2026). Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review. International Journal of Dermatology. https://doi.org/10.1111/ijd.70259
Vancouver
Akiska YM, Gandhi I, Adler R, Fayyad D, Bhagchandani P, Afzal S, et al. Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review. International Journal of Dermatology. 2026. doi:10.1111/ijd.70259
BibTeX
@article{Akiska2026,
author = {Akiska, Yagiz Matthew and Gandhi, Isha and Adler, Robert and Fayyad, Deena and Bhagchandani, Perya and Afzal, Shabnam and Adawi, Waleed and Patel, Shivani and Kwatra, Shawn G},
title = {Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70259}
}
EUVIMED